Hypertension, pulmonary Trials in Toronto, Canada
Conditions / Hypertension, pulmonary / Toronto, Canada
Research into Hypertension, pulmonary spans multiple therapeutic approaches and trial phases.
15 total trials for this combination
Showing top 10 of 15 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04732221 | A Study of the Efficacy and Safety of Frespaciguat (MK-5475) in Participants With Pulmonary Arterial Hypertension (INSIGNIA-PAH: Phase 2/3 Study of an Inhaled sGC Stimulator in PAH) (MK-5475-007) | COMPLETED | PHASE2/PHASE3 |
| NCT00679224 | An Observational Study For Ambrisentan | COMPLETED | — |
| NCT04945460 | A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/A011-16) | COMPLETED | — |
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ENROLLING_BY_INVITATION | PHASE3 |
| NCT01178073 | A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH) | COMPLETED | PHASE3 |
| NCT03626688 | A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients | COMPLETED | — |
| NCT01784562 | Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH) | NO_LONGER_AVAILABLE | — |
| NCT02610660 | Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension | COMPLETED | — |
| NCT04175600 | A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00458276 | Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery | TERMINATED | PHASE3 |